p53 (TP53) (NM_000546) Human Tagged ORF Clone Lentiviral Particle

  • LentiORF®
  • Product Brand Image
SKU
RC200003L4V
Lenti ORF particles, TP53 (mGFP-tagged) - Human tumor protein p53 (TP53), transcript variant 1, 200ul, >10^7 TU/mL
  $1,007.00
In Stock*
Specifications
Specifications
Product Data
Type Human Tagged ORF Clone Lentiviral Particle
Tag mGFP
Target Symbol p53
Synonyms BCC7; BMFS5; LFS1; P53; TRP53
Vector pLenti-C-mGFP-P2A-Puro
Mammalian Cell Selection Puromycin
Sequence Data
ORF Nucleotide Sequence
The ORF insert of this clone is exactly the same as(RC200003).
ACCN NM_000546
ORF Size 1179 bp
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Shipping Dry Ice
Reference Data
RefSeq NM_000546.5
RefSeq Size 2591 bp
RefSeq ORF 1182 bp
Locus ID 7157
UniProt ID P04637, K7PPA8, Q53GA5
Cytogenetics 17p13.1
Domains P53
Protein Families Druggable Genome, Stem cell - Pluripotency, Transcription Factors
Protein Pathways Amyotrophic lateral sclerosis (ALS), Apoptosis, Basal cell carcinoma, Bladder cancer, Cell cycle, Chronic myeloid leukemia, Colorectal cancer, Endometrial cancer, Glioma, Huntington's disease, MAPK signaling pathway, Melanoma, Neurotrophin signaling pathway, Non-small cell lung cancer, p53 signaling pathway, Pancreatic cancer, Pathways in cancer, Prostate cancer, Small cell lung cancer, Thyroid cancer, Wnt signaling pathway
MW 43.7 kDa
Summary This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). provided by RefSeq, Dec 2016
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Characterization of p53 p.T253I as a pathogenic mutation underlying Li-Fraumeni Syndrome
Holcomb, Harrington, Pu et al
PLoS One (2025) 20 (12), e0320036 DOI: 10.1371/journal.pone.0320036
Cited by 1
AI Summary: OriGene’s GFP-tagged p53 lentiviral constructs (Cat. # RC200003L4V) were used to generate stable cell lines expressing wild-type and mutant p53 proteins, enabling the functional characterization of the T253I mutation in this study.
Snippet: HEK p53-/- cells were transduced with a lentivirus containing GFP-tagged p53 (p53 WT-GFP) or mutant derivatives of p53: C176Y-GFP, R213X-GFP or T253I-GFP, all under a cytomegalovirus (CMV) promoter (Origene Cat. # RC200003L4V). Stable lines were selected (puromycin) and expression of constructs confirmed by GFP fluorescence and immunoblotting. Cell growth rate and GFP expression detection by flow
FigureFigureFigure
Characterization of p53 p. T253I as a pathogenic mutation underlying Li-Fraumeni Syndrome
Holcomb, Harrington, Pu et al
medRxiv (2025)
AI Summary: OriGene's GFP-tagged p53 expression constructs (Cat. # RC200003L4V) were used to generate stable cell lines expressing wild-type or mutant p53 proteins, enabling functional characterization of the p53 T253I mutation in this study.
Snippet: ced with a lentivirus containing GFP-tagged p53 (p53 WT-GFP) or mutant derivatives of p53: C176Y-GFP, R213X-GFP or T253I-GFP, all under a cytomegalovirus (CMV) promoter (Origene Cat. # RC200003L4V). Stable lines were selected (puromycin) and expression of constructs
Transcriptional Regulation of Amino Acid Transport in Glioblastoma Multiforme
Umans, Martin, Harrigan et al
Cancers (Basel) (2021) 13 (24) DOI: 10.3390/cancers13246169
Cited by 13
AI Summary: OriGene products contributed to this study by providing the control GFP lentivirus (#PS100093V) and the experimental lentivirus overexpressing p53 conjugated to GFP (#RC200003L4V), which were used to manipulate p53 expression in GBM cells to investigate its regulatory effect on SLC7A11/xCT expression.
Snippet: GFP) (Origene;(Rockville, MD, USA, #PS100093V) or an experimental lentivirus that over-expressed p53 conjugated to GFP (Origene #RC200003L4V). Lentiviruses were used at a multiplicity of infection (MOI) of 2. Transduced cells were selected with two, 48 h
FigureFigureFigure
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products